Monitoring disease response in chronic-phase chronic myeloid leukemia: the age of molecular assays?

Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program

Volumn 2012, Issue , 2012, Pages 111-114

  Yeung, David T ^a   Branford, Susan ^a  

^a SA Pathology ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

AGED; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; DISEASE FREE SURVIVAL; GENETICS; HUMAN; METHODOLOGY; MYELOID LEUKEMIA; ONCOLOGY; REVIEW; RISK; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CYTOGENETICS; DISEASE-FREE SURVIVAL; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOID, CHRONIC-PHASE; MEDICAL ONCOLOGY; RISK; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84879360099     PISSN: None     EISSN: 15204383     Source Type: Journal    
DOI: 10.1182/asheducation.v2012.1.111.3806846     Document Type: Review

References (0)